Marshall Wace North America’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Marshall Wace North America’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$107K	Buy	+4,637	New	+$138K	﹤0.01%	1360
2021 Q2	–	Sell	-10,309	Closed	-$748K	–	1872
2021 Q1	$748K	Buy	+10,309	New	+$732K	﹤0.01%	1114
2020 Q3	–	Sell	-1,446	Closed	-$87K	–	1545
2020 Q2	$87K	Buy	+1,446	New	+$132K	﹤0.01%	1103
2020 Q1	–	Sell	-765	Closed	-$105K	–	1679
2019 Q4	$105K	Buy	+765	New	+$93K	﹤0.01%	1058
2019 Q3	–	Sell	-13,057	Closed	-$1.83M	–	1605
2019 Q2	$1.83M	Buy	+13,057	New	+$2.29M	0.01%	595

Other funds holding ORTX

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Marshall Wace North America's ORTX Position: Q3 2021 in Review

Marshall Wace North America opened a new position in Orchard Therapeutics plc American Depositary Shares (ORTX) in Q3 2021: 4,637 shares worth $107K. The stake represents ﹤0.01% of the portfolio and ranks #1360 among its holdings. This is a return to the name: Marshall Wace North America previously reported a position in ORTX as recently as Q1 2021.

Marshall Wace North America first reported a position in ORTX in Q2 2019 and has held it in 5 quarters since. The position peaked at $1.83M in Q2 2019. 79 funds tracked by Wall St. Rank hold ORTX as of Q3 2021.

Marshall Wace North America held 4,637 shares of Orchard Therapeutics plc American Depositary Shares worth $107K as of Q3 2021.
Orchard Therapeutics plc American Depositary Shares was a new Marshall Wace North America position in Q3 2021.
Orchard Therapeutics plc American Depositary Shares made up ﹤0.01% of Marshall Wace North America's portfolio in Q3 2021, its #1360 holding.
Marshall Wace North America first reported a position in Orchard Therapeutics plc American Depositary Shares in Q2 2019 and has held it in 5 quarters since.
Marshall Wace North America's Orchard Therapeutics plc American Depositary Shares position peaked at $1.83M in Q2 2019.
79 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.